ŠKODA, Jan, Jakub NERADIL, Karel ZITTERBART, Jaroslav ŠTĚRBA a Renata VESELSKÁ. EGFR signaling in the HGG-02 glioblastoma cell line with an unusual loss of EGFR gene copy. Oncology Reports. Athens: Spandidos Publications Ltd, 2014, roč. 31, č. 1, s. 480-487. ISSN 1021-335X. Dostupné z: https://dx.doi.org/10.3892/or.2013.2864.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název EGFR signaling in the HGG-02 glioblastoma cell line with an unusual loss of EGFR gene copy
Autoři ŠKODA, Jan (203 Česká republika, domácí), Jakub NERADIL (203 Česká republika, domácí), Karel ZITTERBART (203 Česká republika, domácí), Jaroslav ŠTĚRBA (203 Česká republika, domácí) a Renata VESELSKÁ (203 Česká republika, garant, domácí).
Vydání Oncology Reports, Athens, Spandidos Publications Ltd, 2014, 1021-335X.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor Genetika a molekulární biologie
Stát vydavatele Řecko
Utajení není předmětem státního či obchodního tajemství
WWW URL
Impakt faktor Impact factor: 2.301
Kód RIV RIV/00216224:14310/14:00074892
Organizační jednotka Přírodovědecká fakulta
Doi http://dx.doi.org/10.3892/or.2013.2864
UT WoS 000330788100065
Klíčová slova anglicky glioblastoma multiforme; epidermal growth factor receptor signaling; PDGFR; TAM receptors; receptor tyrosine kinase; mitogen-activated protein kinase
Štítky AKR, rivok
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: prof. RNDr. Renata Veselská, Ph.D., M.Sc., učo 1260. Změněno: 25. 11. 2015 22:06.
Anotace
Epidermal growth factor receptor (EGFR) gene amplification and the overexpression of EGFR are described as common features of glioblastoma multiforme (GBM). Nevertheless, we previously reported the loss of EGFR gene copy in a GBM specimen from a patient with an unusually favorable course of the disease, and the HGG-02 cell line with this aberration was successfully derived from this tumor. Here, we present a detailed analysis of changes in gene expression and cell signaling in the HGG-02 cell line; the GM7 reference cell line with a standard EGFR gene copy number derived from a very aggressive GBM was used as a control. We confirmed the downregulation of EGFR expression and signaling in HGG-02 cells using different methods (RTK analysis, gene profiling and RT-PCR). Other changes that may have contributed to the non-aggressive phenotype of the primary tumor were identified, including the downregulated phosphorylation of the Axl and Trk receptors, as well as increased activity of JNK and p38 kinases. Notably, differences in PDGF signaling were detected in both of these cell lines; HGG-02 cells preferentially expressed and signaled through PDGFRalpha, and PDGFRbeta was strongly overexpressed and phosphorylated in the GM7 reference cell line. Using expression profiling of cancer-related genes, we revealed the specific profile of HGG-02 cells that included upregulated tumor-suppressors as well as downregulated genes associated with the extracellular matrix. This study represents the first comprehensive analysis of gene expression and cell signaling in glioblastoma cells with lower EGFR gene dosage. As indicated by our results, the TAM receptors, Trk receptors and PDGFRs need to be investigated further since their regulation appears to be important for glioblastoma biological features as well as the clinical course of the disease.
Návaznosti
EE2.3.20.0183, projekt VaVNázev: Centrum experimentální biomedicíny
VytisknoutZobrazeno: 3. 10. 2024 16:19